About Us

The power to predict can strengthen the ability to heal and prevent disease. Prescient Medicine is dedicated to uncovering critical insights that enable more informed, more effective care.


To accelerate the development, commercialization and deployment of advanced clinical diagnostics to address the most pressing public health issues in the U.S.


To act as a catalyst in rapidly evolving the healthcare system to embrace precision medicine and advanced diagnostic testing in order to predict and prevent disease before it starts.


Chief Executive Officer & Medical Director

Chief Information Officer

Chief Operating Officer

Chief Financial Officer

Latest News

FDA Grants Breakthrough Device Designation to the Prescient Metabiomics LifeKit® Prevent Test for the Early Detection of Colon Polyps and Colon Cancer

CARLSBAD, California, September 4th, 2019 -- Prescient Metabiomics, a privately held company…

Read More

Gut microbiome identifies risk for colorectal polyps

Objective To characterise the gut microbiome in subjects with and without polyps and…

Read More

Prescient Medicine Holdings Inc. Acquires AutoGenomics Inc.

Hummelstown, Pennsylvania, April 23, 2019 - Prescient Medicine Holdings Inc. announced today…

Read More